Emerging Biopharma
Merck KGaA signs two deals with BenevolentAI and Exscientia to boost AI-driven drug discovery in oncology and immunology
Anika Sharma
Merck KGaA is making strategic moves in the field of AI-enabled drug discovery by entering into three-target partnerships with BenevolentAI ...
RayzeBio and Neumora raise over $500M combined in successful IPOs for cancer therapies
Anika Sharma
Closing the week on an optimistic note, two biotech IPOs have successfully crossed the finish line with impressive results. RayzeBio, ...
